Search

Peter C. English

Examiner (ID: 17068, Phone: (571)272-6671 , Office: P/3993 )

Most Active Art Unit
3993
Art Unit(s)
3102, 3619, 3642, 3611, 3106, 3993, 3616
Total Applications
1958
Issued Applications
1500
Pending Applications
231
Abandoned Applications
234

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4007685 [patent_doc_number] => 05859308 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Transgenic animals and related aspects' [patent_app_type] => 1 [patent_app_number] => 8/365966 [patent_app_country] => US [patent_app_date] => 1994-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 19 [patent_no_of_words] => 13564 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/859/05859308.pdf [firstpage_image] =>[orig_patent_app_number] => 365966 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/365966
Transgenic animals and related aspects Dec 28, 1994 Issued
Array ( [id] => 3480177 [patent_doc_number] => 05457046 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-10-10 [patent_title] => 'Enzyme capable of degrading cellullose or hemicellulose' [patent_app_type] => 1 [patent_app_number] => 8/361920 [patent_app_country] => US [patent_app_date] => 1994-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 16840 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 283 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/457/05457046.pdf [firstpage_image] =>[orig_patent_app_number] => 361920 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/361920
Enzyme capable of degrading cellullose or hemicellulose Dec 21, 1994 Issued
Array ( [id] => 3840932 [patent_doc_number] => 05707865 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-13 [patent_title] => 'Retroviral vectors for expression in embryonic cells' [patent_app_type] => 1 [patent_app_number] => 8/361112 [patent_app_country] => US [patent_app_date] => 1994-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 20 [patent_no_of_words] => 7843 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/707/05707865.pdf [firstpage_image] =>[orig_patent_app_number] => 361112 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/361112
Retroviral vectors for expression in embryonic cells Dec 20, 1994 Issued
Array ( [id] => 3696277 [patent_doc_number] => 05650503 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-22 [patent_title] => 'Genetic construct of which protein coding DNA comprises introns and is designed for protein production in transgenic animals' [patent_app_type] => 1 [patent_app_number] => 8/359854 [patent_app_country] => US [patent_app_date] => 1994-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 22 [patent_no_of_words] => 17016 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/650/05650503.pdf [firstpage_image] =>[orig_patent_app_number] => 359854 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/359854
Genetic construct of which protein coding DNA comprises introns and is designed for protein production in transgenic animals Dec 19, 1994 Issued
08/346129 DIAGNOSIS OF AND THERAPY FOR HEREDITARY HAEMORRHAGIC TELANGIECTASIA Nov 28, 1994 Abandoned
08/348258 TISSUE-SPECIFIC TREATMENT, DIAGNOSTIC METHODS, AND COMPOSITIONS USING REPLICATION-DEFICIENT VECTORS Nov 27, 1994 Abandoned
Array ( [id] => 4033519 [patent_doc_number] => 05856153 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-05 [patent_title] => 'Suicide genes and new associations of pyrimidine nucleobase and nucleoside analogs with new suicide genes for gene therapy of acquired diseases' [patent_app_type] => 1 [patent_app_number] => 8/343923 [patent_app_country] => US [patent_app_date] => 1994-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9551 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/856/05856153.pdf [firstpage_image] =>[orig_patent_app_number] => 343923 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/343923
Suicide genes and new associations of pyrimidine nucleobase and nucleoside analogs with new suicide genes for gene therapy of acquired diseases Nov 16, 1994 Issued
Array ( [id] => 3982271 [patent_doc_number] => 05861299 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-19 [patent_title] => 'Genetic construct of which protein coding DNA comprises introns and is designed for protein production in transgenic animals' [patent_app_type] => 1 [patent_app_number] => 8/343884 [patent_app_country] => US [patent_app_date] => 1994-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 31 [patent_no_of_words] => 17016 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/861/05861299.pdf [firstpage_image] =>[orig_patent_app_number] => 343884 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/343884
Genetic construct of which protein coding DNA comprises introns and is designed for protein production in transgenic animals Nov 16, 1994 Issued
Array ( [id] => 3882444 [patent_doc_number] => 05714170 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-03 [patent_title] => 'Method of inducing resistance to tumor growth' [patent_app_type] => 1 [patent_app_number] => 8/340732 [patent_app_country] => US [patent_app_date] => 1994-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6400 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/714/05714170.pdf [firstpage_image] =>[orig_patent_app_number] => 340732 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/340732
Method of inducing resistance to tumor growth Nov 15, 1994 Issued
08/340826 METHODS FOR INHIBITING CELL PROLIFERATION BY INHIBITING THE MITOGENIC ACTIVITY OF MACROPHAGE MIGRATION INHIBITORY FACTOR Nov 15, 1994 Abandoned
Array ( [id] => 3728808 [patent_doc_number] => 05652217 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-29 [patent_title] => 'Fibronectin binding protein' [patent_app_type] => 1 [patent_app_number] => 8/340458 [patent_app_country] => US [patent_app_date] => 1994-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4935 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/652/05652217.pdf [firstpage_image] =>[orig_patent_app_number] => 340458 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/340458
Fibronectin binding protein Nov 13, 1994 Issued
Array ( [id] => 3767153 [patent_doc_number] => 05773268 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-30 [patent_title] => 'Chromosome 21 gene marker, compositions and methods using same' [patent_app_type] => 1 [patent_app_number] => 8/337690 [patent_app_country] => US [patent_app_date] => 1994-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 9508 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/773/05773268.pdf [firstpage_image] =>[orig_patent_app_number] => 337690 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/337690
Chromosome 21 gene marker, compositions and methods using same Nov 8, 1994 Issued
08/336534 GENE THERAPY FOR HYPERCHOLESTEROLEMIA Nov 8, 1994 Abandoned
08/335461 ENHANCING THE SENSITIVITY OF TUMOR CELLS TO THERAPIES Nov 6, 1994 Abandoned
08/334567 INSECTICIDAL COMPOSITION CONTAINING HETERORHABDITIS NEMATODES AND PROCESS Nov 3, 1994 Abandoned
Array ( [id] => 3668090 [patent_doc_number] => 05599906 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-04 [patent_title] => 'Protease assays' [patent_app_type] => 1 [patent_app_number] => 8/333901 [patent_app_country] => US [patent_app_date] => 1994-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8119 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/599/05599906.pdf [firstpage_image] =>[orig_patent_app_number] => 333901 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/333901
Protease assays Nov 2, 1994 Issued
Array ( [id] => 3589032 [patent_doc_number] => 05552528 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-03 [patent_title] => 'Bovine b-endothelial cell growth factor' [patent_app_type] => 1 [patent_app_number] => 8/334884 [patent_app_country] => US [patent_app_date] => 1994-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 8547 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/552/05552528.pdf [firstpage_image] =>[orig_patent_app_number] => 334884 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/334884
Bovine b-endothelial cell growth factor Nov 2, 1994 Issued
Array ( [id] => 3586795 [patent_doc_number] => 05550041 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-27 [patent_title] => 'Caffeine demethylate gene-containing DNA fragment and microbial process for producing 3-methyl-7-alkylxanthine' [patent_app_type] => 1 [patent_app_number] => 8/324483 [patent_app_country] => US [patent_app_date] => 1994-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9015 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/550/05550041.pdf [firstpage_image] =>[orig_patent_app_number] => 324483 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/324483
Caffeine demethylate gene-containing DNA fragment and microbial process for producing 3-methyl-7-alkylxanthine Oct 17, 1994 Issued
08/323490 TRANSGENIC NONHUMAN ANIMAL HAVING FUNCTIONALLY DISRUPTED INTERLEUKIN-1BETA CONVERTING ENZYME GENE Oct 13, 1994 Abandoned
Array ( [id] => 3936407 [patent_doc_number] => 05981277 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology' [patent_app_type] => 1 [patent_app_number] => 8/318837 [patent_app_country] => US [patent_app_date] => 1994-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 34 [patent_no_of_words] => 29381 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981277.pdf [firstpage_image] =>[orig_patent_app_number] => 318837 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/318837
Polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology Oct 12, 1994 Issued
Menu